CLARKE JOHN K
SEC CIK 1219015 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ATYR | aTYR PHARMA INC | Dir | 19.8K | — | — | 1 | 2023-04-26 | 2023-04-26 |
Most active insiders at ATYR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | SCHIMMEL PAUL | Dir | $962.3K | — |
| 2 | Shukla Sanjay | Pres, CEO, Dir | — | $3,670 |
| 3 | Broadfoot Jill Marie | CFO | — | $1,527 |
| 4 | DENYES NANCY | GC | — | $1,096 |
CLARKE JOHN K made no open-market trades at ATYR in the last 12 months.
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-04-28 | 2023-04-26 | ATYR | aTYR PHARMA INC | CLARKE JOHN K | Dir | M - OptEx | — | +6,000 | 19.8K | +43% | — |
Purchase Sale Sale after option exercise All abbreviations